(NASDAQ: DYAI) Dyadic International's forecast annual revenue growth rate of 51.14% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.51%.
Dyadic International's revenue in 2026 is $3,802,237.On average, 5 Wall Street analysts forecast DYAI's revenue for 2026 to be $243,264,781, with the lowest DYAI revenue forecast at $174,978,652, and the highest DYAI revenue forecast at $310,785,698. On average, 5 Wall Street analysts forecast DYAI's revenue for 2027 to be $464,994,289, with the lowest DYAI revenue forecast at $249,969,503, and the highest DYAI revenue forecast at $689,529,577.
In 2028, DYAI is forecast to generate $408,842,248 in revenue, with the lowest revenue forecast at $392,809,218 and the highest revenue forecast at $420,867,020.